New injection may beat standard keloid therapy

NCT ID NCT07201766

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a drug called bleomycin works better than the usual combination of 5-FU and triamcinolone for shrinking keloids (raised scars). About 104 people aged 13-60 with keloids will receive injections into their scars. Researchers will measure scar improvement over 12 weeks using a standard scar scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KELOIDS SCARS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King Edward Medical University

    Lahore, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.